A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

NCT04557098 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

194

Enrollment

INDUSTRY

Sponsor class

Conditions

Hematological Malignancies

Interventions

DRUG: Teclistamab

Sponsor

Janssen Research & Development, LLC